高级检索
当前位置: 首页 > 详情页

Comparison of safety and efficacy of posterior lumbar interbody fusion (PLIF) and modified transforaminal lumbar interbody fusion (M-TLIF) in the treatment of single-segment lumbar degenerative diseases

文献详情

资源类型:
Pubmed体系:
机构: [1]Guangzhou University of Traditional Chinese Medicine, Guangdong, China. [2]Department of Orthopedic, The First Afliated Hospital of Guangzhou University of Chinese Medicine, No. 16, Airport Road, Baiyun District, Guangzhou 510000, China. [3]Department of Orthopedic, Baiyun Hospital of the First Afliated Hospital of Guangzhou University of Chinese Medicine, Helong 7 Road, Baiyun District, Guangzhou 510000, China. [4]Department of Orthopedic, Zhanjiang First Hospital of Traditional Chinese Medicine, Zhanjiang, China. [5]Jiang Yang Urban Construction Vocational School Abstract, Luzhou, China.
出处:

关键词: Modifed transforaminal lumbar interbody fusion Posterior lumbar interbody fusion Lumbar degenerative diseases Postoperative complications Adjacent segmental degeneration

摘要:
To compare modified transforaminal lumbar interbody fusion (M-TLIF) with posterior lumbar interbody fusion (PLIF) in the treatment of single-segment lumbar degenerative disorders in order to assess its safety and effectiveness.From January 2016 to January 2021, 74 patients who received single-segment M-TLIF were examined. A total of 74 patients having single-segment PLIF during the same time period were included in a retrospective controlled study using the same inclusion and exclusion criteria. The two groups were compared in terms of the fusion rate, the Oswestry disability index (ODI), the visual analogue scale of low back pain (VAS), the perioperative condition, the postoperative complications, and the postoperative neighbouring segment degeneration.All patients had surgery satisfactorily and were monitored for at least a year afterwards. The baseline values for the two groups did not significantly differ. The interbody fusion rate between PLIF (98.65%) and M-TLIF (97.30%) was not significantly different. In the follow-up, the M-TLIF group's VAS score for low back and leg pain was lower than that of the PLIF group. The ODI score of the M-TLIF group was lower than that of the PLIF group at 7 days and 3 months following surgery. Both groups' post-op VAS and ODI scores for low back and leg pain were much lower than those from before the procedure. In M-TLIF group, the operation time, drainage tube extraction time, postoperative bed rest time and hospital stay time were shorter, and the amount of intraoperative blood loss was less. Compared with those before operation, the height of intervertebral space and intervertebral foramen were significantly increased in both groups during postoperative follow-up (P < 0.05). The postoperative complications and adjacent segment degeneration of M-TLIF were significantly lower than those of PLIF.M-TLIF is a safe and effective treatment for lumbar degenerative disorders, with a high fusion rate and no significant difference between M-TLIF and PLIF. M-TLIF's efficacy and safety are comparable to that of PLIF, particularly in terms of early relief of low back pain and improvement in quality of life following surgery. Therefore, M-TLIF technology can be popularized and applied in clinic.© 2024. The Author(s).

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 骨科
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 骨科
第一作者:
第一作者机构: [1]Guangzhou University of Traditional Chinese Medicine, Guangdong, China. [2]Department of Orthopedic, The First Afliated Hospital of Guangzhou University of Chinese Medicine, No. 16, Airport Road, Baiyun District, Guangzhou 510000, China.
共同第一作者:
通讯作者:
通讯机构: [2]Department of Orthopedic, The First Afliated Hospital of Guangzhou University of Chinese Medicine, No. 16, Airport Road, Baiyun District, Guangzhou 510000, China. [3]Department of Orthopedic, Baiyun Hospital of the First Afliated Hospital of Guangzhou University of Chinese Medicine, Helong 7 Road, Baiyun District, Guangzhou 510000, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号